New Zealand’s aging population means that the incidence of cancer is growing exponentially, and over 65s have the highest rate of cancers requiring treatment. The effects are far reaching – from the impact on the patient, their families and friends, to the providers, the budget and broader economy.
Chair of CANGO Graeme Woodside said “CANGO’s purpose to is collaborate with cancer charities, and lobby the Government strategically especially in election years. More than 23,000 New Zealanders will be diagnosed with cancer this year, and it’s the country’s single biggest cause of death. One in three cancer patients will be cured, but we want to see that statistic improved through better research and treatment, and more education about cancer prevention”.
From ensuring all New Zealanders have access to diagnosis, care and treatment to addressing disparities in care for Maori, access for rural communities, and responding to the rapidly changing environment by ensuring faster decision making by PHARMAC, CANGO will be lobbying unashamedly until the election.
CANGO is seeking increased investment in clinical trials to address ongoing needs of cancer survivors and the aging population. Another of CANGO’s focuses is reducing modifiable risk factors – ensuring New Zealanders eat healthy and balanced diets, and participate in regular exercise.